[Palliative Sedation - Despite Guidelines a Difficult Process of Decisions].

Area of Science:

• Palliative Care
• Medical Ethics
• Pharmacology

Background:

• Distinguishing between different sedation levels (minimal, moderate, deep) and types (intermediate, continuous) is essential in medical practice.
• Palliative sedation (PS) aims to alleviate patient suffering, necessitating ethical considerations regarding drug dosage and administration.
• Understanding the specific applications of intermittent versus continuous PS is crucial for symptom management.

Purpose of the Study:

• To clarify the distinctions between various types and levels of sedation used in palliative care.
• To emphasize the ethical imperative of using minimally required doses in palliative sedation.
• To outline the indications and requirements for implementing palliative sedation.

Main Methods:

• Review of current literature and clinical guidelines on palliative sedation.
• Analysis of the differences between intermittent and continuous sedation techniques.
• Identification of key ethical considerations and prerequisites for palliative sedation.

Main Results:

• Palliative sedation requires differentiation between intermediate/continuous and minimal/moderate/deep sedation.
• Minimally required doses are ethically crucial for decreasing suffering in PS.
• Intermittent PS targets physical symptoms; deep continuous PS addresses intolerable psychological suffering.

Conclusions:

• Precise medical indication and comprehensive education of patients and relatives are prerequisites for PS.
• Midazolam is a commonly used agent for palliative sedation.
• Frequent monitoring and personal assistance are mandatory for all PS cases.